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Previous data suggest that a~lograft accelerated arterio- 
eclerosis is due to prolonged antibody-mediated endothe- 
lial injury and resultant occlusive ineimal proliferation. 
Evidence from 6 cases of transplanted patients who died 
at differene Intervals (1-14 months) post-transplantation 
revealed mononuclear cell infiltration of the arterial 
wall of secondary, eertiary, and penetrating branches of 
coronary arteries. The infiltrate consisted of T-lymph- 
ocytes, mscrophagea, and rare dendritic cells involving 
primarily the outer half of the media and adventitia and 
resulting in destruction of the external elastica. The 
endothelium and internal elastica were uninvolved in 
early post-transplantatfon cases. CMV sequences were 
identified in the myocardium by in situ hybridization 
techniques in 3 cases (1-5 months). C’W, however* was 
not Identified in the wall of the inflamed intramyocar- 
dial coronary arteries. 
If the cellular response is against CMV encoded deter- 
minants, these data suggest that it is most likely due 
to “antigenic mimicry” by determinants of smooth muscle 
cells or due to passive acquisition of CMV antigens by 
structures of the injured cells. 
The ability to culture, grow and expand mononuclear cells 
from such injured tissues may eventually allow for the 
characterization of the antigenic specificity of the 
fnf iltrate. Such seudies are in progress. 
~~~S~~~~~ ~~~~Tn~L~AL ~~p~N~~NT RESPONSE TO ~~T~~~~O~A~~ 
SUBSTANCE P IN CARDIAC T SPLA.KT RECIPPENTS. 
S. Kushwaha MRCP, M. Bustami MBBS, D. Grossman riRCP, 
A. Maser% D PACC, A. Mitchell HRCP, M. Yacoubl FRCS. 
CWii0hg)J Cardiac Surgical UnitsI Harefield 
Cardiology Unit, RPMS, Wammersmith Hospital, London, U.K. 
The endothelium dependent vasodilator substance P (sp) 
dilates normal and iseesed coronary arteries in man in 
vivo snd produces a maximal 
with ~n~racoronary isosorbi 
cardiac transparent recipien 
fusions of SP following their annual investig- 
patients were well with no evidence of reject-- 
ion and with angiographicaI.ly normal coronary arteries and 
no evidence of accelerated sclerosis. SP in increasing 
doses was infused at 2ml/min for 2 minutes into the left 
coronary circulation in 11 TxR and right coronary artery 
in 1 TxR followed by 2mgs of ISDN infused over 2 minutes. 
Coronary artery diameters were measured in 23 vessel 
segmemts in 12 TxR. The mean % increase in diameter to 
increasing SP dose were as follows: 
SP (pmol/l) saline 1.4 2.8 5.6 11.2 22.4 TSDN 
X increase 0 4,5 10.9 12.1 16.5 19.2 25.8 
SEM 0 2.9 2.9 2.9 2,6 3.1 2.2 
InPSvessel segments measured the maximal response 
occurred at the 2 maximal doses of SP and the remainder 
produced the maximal response at lower doses of 2.8 and 
5.6pmolJ9. The maximal response to SP was 22% f 2,5% (mean 
X diameter change 2 1 SEW. This was not significantly 
different frcm ehat achieved with ISDN. There is proserved 
er:dothelial dependent vasodilaeion in TxR coronary arteries 
to SP comparable to that seen with nitrates. It is con- 
clued in this study that coronary endothelial function is 
preserved in TxR’s and that SP provides a useful tool for 
teseing endothelial function in these patients. 
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Genetic ~omoge~e~t~ was pre&xmedr thus graft 
rejection was not expecte and immunosuppressive 
therapy was not given. 
evaluat 
occurre ut histologic evidence of mo 
severe 
mononuclear cell infiltration with perivascu- 
litis) was seen iu 3/12 SHR-SHR and in 71’12 
WRY-WKY grafts a Of the remaining animal8 S/7 
SHR-SHR and 5/S WKY-WKY grafts exhibited an 
accelerated arteriosclerotic lesio 
in human cardiac gra 
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th minimal 
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her evidence is t 
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